Hashimoto Yasuhiro, Imanishi Kengo, Okamoto Akiko, Sasaki Atsushi, Saitoh Hisao, Wada Ryuichi, Yamamoto Hayato, Koie Takuya, Ohyama Chikara
Oyokyo Kidney Research Institute, Hirosaki Hospital, Hirosaki, Japan.
Case Rep Oncol. 2011 Sep;4(3):517-20. doi: 10.1159/000334081. Epub 2011 Oct 17.
Signet ring cell carcinoma (SRCC) of the prostate is rare, with approximately 100 case reports to date. Here we report a very aggressive case of SRCC of the prostate in a Japanese man. The patient received estramustine, docetaxel, and carboplatin combination chemotherapy, followed by TS-1 and CPT-11 combination therapy. Unfortunately, the disease progressed, and he died of general metastatic disease treated over 16 month with systemic chemotherapy.
前列腺印戒细胞癌(SRCC)较为罕见,迄今为止约有100例病例报告。在此,我们报告一例日本男性侵袭性很强的前列腺SRCC病例。该患者接受了雌莫司汀、多西他赛和卡铂联合化疗,随后接受替吉奥和伊立替康联合治疗。不幸的是,疾病进展,患者在接受16个月全身化疗后死于全身转移性疾病。